Saturday, 10 October 2026European Markets

ST DUPONT Stock Was Up By 9.02% Before The Weekend

Loading stream...

(vianews) - the market ended the session with st dupont (dpt.pa) rising 9.02% to €0.09 on friday, after two sequential sessions in a row of losses. cac 40 rose 0.2% to €7,292.80, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

st dupont's last close was €0.08, 43% under its 52-week high of €0.14.

about st dupont

s.t. dupont s.a. designs, manufactures, and sells luxury products in france and internationally. the company offers lighters, pens, and leather goods; accessories, such as belts, tie bars, money clips, and key rings; cigar accessories and ashtrays; writing accessories; and fragrances. it sells its products through stores and online. s.t. dupont s.a. was incorporated in 1934 and is based in faverges, france. s.t. dupont s.a. is a subsidiary of d and d international b.v.

earnings per share

as for profitability, st dupont has a trailing twelve months eps of €-0.01.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -115.39%.

more news about st dupont (dpt.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com